blog

COVID-19 Response Teaches Industry that Investing in Patient Partnership is Key to all Research Endeavors

By Joan F. Bachenheimer, Founding Principal, CEO on Thu, May 28, 2020 | 6 min read

 

Rapid Adoption of Patient-centric Innovation Seen as Positive Outcome of COVID-19 Research Collaborations

While COVID-19 has severely affected many industries, scientific pursuit for a host of medical conditions is also threatened by sharply negative effects of the pandemic on clinical research for non-COVID-19-related pursuits. This is evidenced by an industry-reported 65 percent decline in new patient study enrollment in March 2020 relative to March 2019. The industry is adapting by borrowing from the zealous approach associated with COVID-19 research by deploying extraordinary collaboration and patient-centric services to achieve timelines for as many studies as possible.

Topics: Patient Centricity, Clinical Research, Clinical Trials, Clinical Trial Innovations, COVID-19, Joan F. Bachenheimer

 
Subscribe To Our Blog